Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2020

Open Access 01-11-2020 | Aortic Valve Replacement | Original Article

Permanent pacemaker implantation rates following cardiac surgery in the modern era

Authors: Jason Kho, Adam Ioannou, Katie E. O’Sullivan, Mark Jones

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2020

Login to get access

Abstract

Aims

The aim of this study was to evaluate the incidence of permanent pacemaker (PPM) implantation after cardiac surgery in our institution and investigate risk factors for PPM dependency to provide patients with accurate incidence figures at the time of consent for surgery.

Methods

Data was collected retrospectively from a single tertiary institution from October 2018 to April 2019 inclusive of 403 patients. Incidence of PPM implantation after various cardiac operations was evaluated. A univariate analysis was carried out to identify the independent risk factors related to PPM implantation.

Results

Ten patients required a PPM (2.48%). The most common indication for PPM implantation post-cardiac surgery was complete heart block (N = 7, 70%) followed by bradycardia/pauses (N = 2, 20%) and sick sinus syndrome (N = 1, 10%). PPM implantation after coronary artery bypass graft (CABG) surgery was the lowest (0.63%), while combined CABG and valve operations had the highest incidence (5.97%). Independent risk predictors for PPM implantation included female gender (p = 0.03), rheumatic heart disease (p = 0.008), pulmonary hypertension (p = 0.01), redo operations (p = 0.002), mitral valve procedures (p = 0.001), tricuspid valve procedures (p = 0.0003) and combined mitral and tricuspid valve procedures (p = 0.0001). Average length of intensive care unit (ICU)/high-dependency unit (HDU) stay was significantly prolonged for patients who required a PPM post-cardiac surgery.

Conclusion

As clinicians, it can be challenging to provide our patients with accurate information on the risk of PPM implantation relative to their operation. A unit-specific data may be a more accurate method of informing our patients on this risk.
Literature
1.
go back to reference Gordon RS, Ivanov J, Cohen G, Ralph-Edwards AL (1998) Permanent cardiac pacing after a cardiac operation: predicting the use of permanent pacemakers. Ann Thorac Surg 66(5):1698–1704CrossRef Gordon RS, Ivanov J, Cohen G, Ralph-Edwards AL (1998) Permanent cardiac pacing after a cardiac operation: predicting the use of permanent pacemakers. Ann Thorac Surg 66(5):1698–1704CrossRef
2.
go back to reference Del Rizzo DF, Nishimura S, Lau C et al (1996) Cardiac pacing following surgery for acquired heart disease. J Card Surg 11(5):332–340CrossRef Del Rizzo DF, Nishimura S, Lau C et al (1996) Cardiac pacing following surgery for acquired heart disease. J Card Surg 11(5):332–340CrossRef
3.
go back to reference Emlein G, Huang SK, Pires LA et al (1993) Prolonged bradyarrhythmias after isolated coronary artery bypass graft surgery. Am Heart J 126(5):1084–1090CrossRef Emlein G, Huang SK, Pires LA et al (1993) Prolonged bradyarrhythmias after isolated coronary artery bypass graft surgery. Am Heart J 126(5):1084–1090CrossRef
4.
go back to reference Kusumoto FM, Goldschlager N (1996) Cardiac pacing. N Engl J Med 334(2):89–97CrossRef Kusumoto FM, Goldschlager N (1996) Cardiac pacing. N Engl J Med 334(2):89–97CrossRef
5.
go back to reference Koplan BA, Stevenson WG, Epstein LM et al (2003) Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery. J Am Coll Cardiol 41(5):795–801 Koplan BA, Stevenson WG, Epstein LM et al (2003) Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery. J Am Coll Cardiol 41(5):795–801
6.
go back to reference Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620 Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620
7.
go back to reference Reardon MJ, Van Mieghem NM, Popma JJ et al (2017) Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 376(14):1321–1331CrossRef Reardon MJ, Van Mieghem NM, Popma JJ et al (2017) Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 376(14):1321–1331CrossRef
8.
go back to reference Roten L, Wenaweser P, Delacretaz E et al (2010) Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol 106(10):1473–1480CrossRef Roten L, Wenaweser P, Delacretaz E et al (2010) Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol 106(10):1473–1480CrossRef
9.
go back to reference Dawkins S, Hobson AR, Kalra PR et al (2008) Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors. Ann Thorac Surg 85(1):108–112 Dawkins S, Hobson AR, Kalra PR et al (2008) Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors. Ann Thorac Surg 85(1):108–112
10.
go back to reference Van Mieghem NM, Head SJ, de Jong W et al (2012) Persistent annual permanent pacemaker implantation rate after surgical aortic valve replacement in patients with severe aortic stenosis. Ann Thorac Surg 94(4):1143–1149CrossRef Van Mieghem NM, Head SJ, de Jong W et al (2012) Persistent annual permanent pacemaker implantation rate after surgical aortic valve replacement in patients with severe aortic stenosis. Ann Thorac Surg 94(4):1143–1149CrossRef
11.
go back to reference Lewis JW Jr, Webb CR, Pickard SD et al (1998) The increased need for a permanent pacemaker after reoperative cardiac surgery. J Thorac Cardiovasc Surg 116(1):74–81 Lewis JW Jr, Webb CR, Pickard SD et al (1998) The increased need for a permanent pacemaker after reoperative cardiac surgery. J Thorac Cardiovasc Surg 116(1):74–81
12.
go back to reference Marcus RH, Sareli P, Pocock WA et al (1994) The spectrum of severe rheumatic mitral valve disease in a developing country. Correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae. Ann Intern Med 120:177–183CrossRef Marcus RH, Sareli P, Pocock WA et al (1994) The spectrum of severe rheumatic mitral valve disease in a developing country. Correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae. Ann Intern Med 120:177–183CrossRef
13.
go back to reference Sliwa K, Carrington M, Mayosi BM et al (2010) Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J 31:719–727 Sliwa K, Carrington M, Mayosi BM et al (2010) Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J 31:719–727
14.
go back to reference Martinez-Selles M, Garcia-Fernandez MA, Moreno M et al (2006) Influence of gender on the etiology of mitral regurgitation. Rev Esp Cardiol 59(12):1335–1338CrossRef Martinez-Selles M, Garcia-Fernandez MA, Moreno M et al (2006) Influence of gender on the etiology of mitral regurgitation. Rev Esp Cardiol 59(12):1335–1338CrossRef
15.
go back to reference Jokinen JJ, Turpeinen AK, Pitkanen O et al (2009) Pacemaker therapy after tricuspid valve operations: implications on mortality, morbidity, and quality of life. Ann Thorac Surg 87(6):1806–1814CrossRef Jokinen JJ, Turpeinen AK, Pitkanen O et al (2009) Pacemaker therapy after tricuspid valve operations: implications on mortality, morbidity, and quality of life. Ann Thorac Surg 87(6):1806–1814CrossRef
16.
go back to reference Jouan J, Mele A, Florens E et al (2016) Conduction disorders after tricuspid annuloplasty with mitral valve surgery: implications for earlier tricuspid intervention. J Thorac Cardiovasc Surg 151(1):99–103 Jouan J, Mele A, Florens E et al (2016) Conduction disorders after tricuspid annuloplasty with mitral valve surgery: implications for earlier tricuspid intervention. J Thorac Cardiovasc Surg 151(1):99–103
17.
go back to reference Rajdev A, Garan H, Biviano A (2012) Arrhythmias in pulmonary arterial hypertension. Prog Cardiovasc Dis 55(2):180–186CrossRef Rajdev A, Garan H, Biviano A (2012) Arrhythmias in pulmonary arterial hypertension. Prog Cardiovasc Dis 55(2):180–186CrossRef
18.
go back to reference Ensminger S, Fujita B, Bauer T et al (2018) Rapid deployment versus conventional bioprosthetic valve replacement for aortic stenosis. J Am Coll Cardiol 71(13):1417–1428 Ensminger S, Fujita B, Bauer T et al (2018) Rapid deployment versus conventional bioprosthetic valve replacement for aortic stenosis. J Am Coll Cardiol 71(13):1417–1428
19.
go back to reference Khurshid S, Epstein AE, Verdino RJ et al (2014) Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm 11(9):1619–1625 Khurshid S, Epstein AE, Verdino RJ et al (2014) Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm 11(9):1619–1625
20.
go back to reference Berdajs D, Schurr UP, Wagner A et al (2008) Incidence and pathophysiology of atrioventricular block following mitral valve replacement and ring annuloplasty. Eur J Cardiothorac Surg 34(1):55–61 Berdajs D, Schurr UP, Wagner A et al (2008) Incidence and pathophysiology of atrioventricular block following mitral valve replacement and ring annuloplasty. Eur J Cardiothorac Surg 34(1):55–61
Metadata
Title
Permanent pacemaker implantation rates following cardiac surgery in the modern era
Authors
Jason Kho
Adam Ioannou
Katie E. O’Sullivan
Mark Jones
Publication date
01-11-2020

Other articles of this Issue 4/2020

Irish Journal of Medical Science (1971 -) 4/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.